Monthly Archives: August 2017

ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / August 30, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Acorda Therapeutics, Inc. (“Acorda” or the “Company”) (NASDAQ: ACOR).

On August 29, 2017, Acorda announced that it had received a Refusal to File letter from the U.S. Food and Drug Administration (“FDA”), which informed the Company that its New Drug Application for INBRIJA (CVT-301) “was not sufficiently complete to permit a substantive review.”

On this news, Acorda’s share price significantly declined.

If you invested in Acorda stock or options between February 9, 2017 and August 28, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/ACOR. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 474194

3 Stocks Capitalizing Off Positive Market Momentum On Wednesday

CORAL GABLES, FL / ACCESSWIRE / August 30, 2017 / Wall Street expands gains in early afternoon trading on Wednesday as stronger-than-anticipated U.S. economic growth data offset concerns about heightening tensions between the U.S. and North Korea. Also, data was released today from payroll processor ADP that showed U.S. private employers added 237,000 jobs in August for its largest monthly advance in over five months. With that being said, here are 3 stocks that are capitalizing off of today’s positive momentum: Medical Imaging Corp. (MEDD), Mannkind Corp. (NASDAQ: MNKD) and LiNiu Technology Group (LINU).

Medical Imaging Corp. (MEDD) is a provider of comprehensive medical imaging services to patients and client hospitals throughout the U.S. and Canada. The company currently operates four Diagnostic Imaging Centers and they recently announced they upgraded their CT machine at their Naples, Florida location.

“Our Naples CT business has been growing throughout 2017, so it was important to have the software installed to meet the new federal standards and ensure that we had a stronger and newer CT machine with greater up time as we approach the start of our busy season this fall,” quoted Mitch Geisler, CEO. “The machine has now been installed and we can resume scanning CT patients this week.”

(MEDD) has been trading in the price range of $0.09-0.10 over the course of this trading week. Throughout Wednesday’s trading session (MEDD) has seen a price per share swing of 33.33% from lows of $0.075 to daily highs of $0.10.

Mannkind Corp. (MNKD) is a biotech company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. During Wednesday’s afternoon trading session, (MNKD) has increased 21% from daily lows of $1.65 to intraday highs at $2.00. Although MNKD missed earning expectations earlier this month, investors seem to be optimistic about the company’s inhale rapid-acting mealtime insulin, Afrezza. Sales for Afrezza have been advancing and accounted for $1.5 million of the company’s revenue for Q2.

LiNiu Technology Group (LINU) is seeing an increase in trading activity during Wednesday’s trading session. The stock is up over 21% from daily lows of $1.79 to highs on the day of $2.18. (LINU) announced on Tuesday (8/29) announced it has signed a strategic cooperation agreement with Shou Guang Agriculture Logistic Park, one of the biggest vegetable distribution, pricing information exchanges and logistic centers throughout Asia.

“We are pleased to embark on our new relationship with SGALP, which we believe will be a key strategic alliance that should provide a significant boost to our LiNiuYang platform, while allowing us to further utilize our technological capabilities to the benefit of SGALP,” stated Mr. Wang Shun Yang, co-Chief Executive Officer of LiNiu Technology Group.

For free up to the minute financial news updates, text keyword HFNEWS to 474747.

About HeraldFinance.com

HeraldFinance.com (“HF”) is owned by MAD Media Publishing LLC, a Nevada corporation. HF produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. HF has not been compensated: an affiliate company of HF, MIDAM VENTURES LLC, has been compensated $150,000 by a non-affiliate 3rd party for a period beginning 8/8/2017 and ending 9/7/2017 to publicly disseminate information about MEDD. We own zero shares.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither HF nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.HeraldFinance.com/.

NO WARRANTY

HF, the Author, and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect, or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

Contact:

editor@heraldfinance.com

SOURCE: HeraldFinance.com

ReleaseID: 474212

Parrish Medical Center Hailed as One of America’s Safest Hospitals by Visiting National Hospital Safety Leader

TITUSVILLE, FL / ACCESSWIRE / August 30, 2017 / Preventable hospital errors lead to the deaths of thousands of Americans annually, but lives are being saved because Parrish Medical Center (PMC) and a growing number of other U.S. hospitals are making patient safety their priority, the leader of one of America’s premier healthcare safety organizations told PMC care partners this month.

Leah Binder, president and CEO of The Leapfrog Group, a national non-profit organization promoting “giant leaps” in healthcare quality and safety, was in Titusville on Aug. 8 to tour PMC and congratulate its board of directors and staff on being one of only 63 (of 2,600) U.S. hospitals since 2012 to earn the Leapfrog Group’s patient safety ‘A’ grade in every grading period to date.

PMC is the sole central Florida hospital over that same period to achieve straight-A grades from The Leapfrog Group. The Leapfrog Group estimates that preventable hospital errors cost some 1,000 Americans their lives every day.

“People’s lives and health are better protected in hospitals that make safety their priority,” Binder told PMC board members, administration, employees and volunteers gathered in the hospital’s atrium. “To earn four straight ‘A’ grades is evidence, for everyone to see, of Parrish Medical Center’s determination to serve its patients well and safely.”

The average cost of a hospital-acquired surgical site infection is $39,000, demonstrating the financial impact that is also affected by hospital safety, she said.

“Hospital safety can’t be a slogan, an objective, or a desire; it has to be a daily, hourly, minute-by-minute commitment and practice because lives are literally at stake,” said George Mikitarian, PMC president and CEO.

“PMC was honored that Leah Binder would come here personally to tour the hospital, and to meet the care partners responsible for not only setting patient safety as a goal, but achieving it in a manner equaled by few American hospitals,” Mikitarian said.

The Leapfrog Group was formed by employers and other large healthcare purchasers to bring about significant healthcare improvements. The Leapfrog Group’s Hospital Survey enables healthcare purchasers to make informed decisions on which hospitals are safest and where they can receive the highest-value care.

The Leapfrog Group assigns A, B, C, D, and F, grades based on a composite of 30 safety measures covering injuries, infections, and errors. Included in the survey are management practices that promote quality and safety; maternity care outcomes; high-risk procedure outcomes; and hospital acquired condition prevalence and medication safety.

A recent national example of the importance of hospital safety was the aftermath of the June 14 shooting in Arlington, Va., of U.S. Rep. Steve Scalise. His condition, at first listed as critical, improved to fair until an infection caused him to be readmitted to the intensive care unit. The hospital in which Rep. Scalise was treated had received a ‘D’ grade from The Leapfrog Group.

“PMC is one of America’s safest hospitals,” Mikitarian said. “We’re grateful to Ms. Binder for coming here personally to deliver that message to all PMC care partners.”

Left to right: Aluino Ochoa, MD, president, Parrish Medical Staff; Herman Cole, Jr., PMC board chairman; George Mikitarian, PMC president and CEO; Leah Binder, The LeapFrog Group president and CEO; and Edwin Loftin, PMC vice president, Acute Care Services/CNO

For a brief video of Leah Binder being interviewed by USA Today’s Jayne O’Donnell following the shooting of Rep. Steve Scalise: https://www.usatoday.com/search/leah%20binder/

To review the Leapfrog Hospital Safety Grades for Brevard County hospitals: http://www.hospitalsafetygrade.org/search?findBy=zip&zip_code=32926&radius=50&city=&state_prov=&hospital

About The Leapfrog Group

Founded in 2000 and based in Washington, D.C., The Leapfrog Group is a national nonprofit watchdog organization that serves as a voice for health care purchasers, using their collective influence to foster positive change in U.S. health care. Leapfrog is the nation’s premier advocate of hospital transparency – collecting, analyzing and disseminating hospital data to inform value-based purchasing. The Leapfrog Group uses national performance measures from numerous sources, including the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC), and other survey methods, to twice annually survey some 2,600 U.S. general acute-care hospitals.

About Parrish Medical Center

Parrish Medical Center (PMC), a Parrish Healthcare integrated care partner, is located at 951 N. Washington Ave., Titusville, Florida. The 210-bed, not-for-profit acute care public medical center has been serving Brevard County for nearly 60 years. PMC is nationally recognized as One of America’s finest healing environments®. PMC has earned top rankings on The SafeCare Group’s Top 100 SafeCare Hospitals® since 2015. The Joint Commission consistently names PMC as a Top Performer on Key Quality Measures, recognizing PMC for “exemplary performance in using evidence-based clinical processes that are shown to improve care.” The hospital has earned straight “A” safety ratings (since 2012) from The Leapfrog Group. In 2014, Consumer Reports recognized PMC as Florida’s safest hospital. PMC, as compared to other U.S. hospitals, maintains top-tier national rankings for clinical outcomes, safety and patients’ experiences. For more information, visit www.parrishmed.com.

CONTACT:

VERONICA DENT, APR
DIRECTOR, COMMUNICATIONS & COMMUNITY SERVICES
321-268-6110

SOURCE: Parrish Medical Center

ReleaseID: 474209

The Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of Applied Optoelectronics, Inc. Shareholders and a Lead Plaintiff Deadline of October 4, 2017

NEW YORK, NY / ACCESSWIRE / August 30, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Applied Optoelectronics, Inc. (NASDAQ: AAOI) who purchased shares between July 13, 2017 and August 3, 2017. The action, which was filed in the United States District Court for the Southern District of Texas, alleges that the Company violated federal securities laws.

In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) a major customer was reducing its purchases of the Company’s 40G receivers; (2) the loss of this major customer’s business would have a severe negative impact on the Company’s financial performance; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Shareholders have until October 4, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.

If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sb/applied-optoelectronics-inc?wire=1.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 474208

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Envision Healthcare Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 3, 2017 – EVHC

NEW YORK, NY / ACCESSWIRE / August 30, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Envision Healthcare Corporation (“Envision Healthcare”) (NYSE: EVHC) between March 2, 2015 and July 21, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Middle District of Tennessee. To get more information go to: http://www.zlk.com/pslra-sba/envision-healthcare-corporation?wire=1 or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Envision Healthcare subsidiary EmCare Holdings, Inc. routinely arranged for patients who sought treatment at in-network facilities to be treated by out-of-network physicians; (ii) EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians; (iii) the Company’s statements attributing EmCare’s Class Period growth to other factors were therefore false and/or misleading; (iv) Envision’s EmCare revenues were likely to be unsustainable after the foregoing conduct came to light; and (v) as a result of the foregoing, Envision’s public statements were materially false and misleading at all relevant times.

If you suffered a loss in Envision Healthcare you have until October 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 474203

TAHO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tahoe Resources Inc. and a Lead Plaintiff Deadline of September 5, 2017

NEW YORK, NY / ACCESSWIRE / August 30, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of investors who purchased Tahoe Resources Inc. (“Tahoe Resources”) (NYSE: TAHO) securities between April 3, 2013 and July 5, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sbm/tahoe-resources-inc?wire=1. There is no cost or obligation to you.

The complaint alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Tahoe’s exploitation license of the Escobal mine assets was in violation of the indigenous people’s rights to be consulted; (2) Tahoe was not in compliance with governmental law and regulations; and (3) as a result of the foregoing, Defendants’ statements about Tahoe’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

If you suffered a loss in Tahoe Resources, you have until September 5, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sbm/tahoe-resources-inc?wire=1.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 474204

OCUL EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ocular Therapeutix, Inc. and a Lead Plaintiff Deadline of September 5, 2017

NEW YORK, NY / ACCESSWIRE / August 30, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Ocular Therapeutix, Inc. (“Ocular Therapeutix”) (NASDAQ: OCUL) securities between March 10, 2016 and July 11, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sb/ocular-therapeutix-inc?wire=1. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (i) Ocular failed to adequately address issues identified in the First Form 483; (ii) Ocular’s re-submitted NDA would not be approved by the July 19, 2017 PDUFA date because the Company could not timely and adequately address the FDA-identified manufacturing and control issues; (iii) Ocular’s continued manufacturing issues imperil the approval of DEXTENZA; and (v) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

If you suffered a loss in Ocular Therapeutix, you have until September 5, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sb/ocular-therapeutix-inc?wire=1.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 474205

CMG INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Chipotle Mexican Grill, Inc. and a Lead Plaintiff Deadline of September 18, 2017

NEW YORK, NY / ACCESSWIRE / August 30, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of investors who purchased Chipotle Mexican Grill, Inc. (“Chipotle Mexican Grill”) (NYSE: CMG) securities between February 5, 2016 and July 19, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sb/chipotle-mexican-grill-inc?wire=1. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (i) Chipotle’s purported improvements in its restaurants’ food safety policies were inadequate; (ii) accordingly, Chipotle’s quality controls were still not in compliance with applicable consumer and workplace safety regulations; (iii) in turn, Chipotle’s quality controls remained inadequate to safeguard consumer and employee health; and (iv) as a result of the foregoing, Chipotle’s public statements were materially false and misleading at all relevant times.

If you suffered a loss in Chipotle Mexican Grill, you have until September 18, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sb/chipotle-mexican-grill-inc?wire=1.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 474206

Parrish Healthcare Center at Port Canaveral Now Open

New Facility Provides Occupational Medicine, Primary Care and Other Services

TITUSVILLE, FL / ACCESSWIRE / August 30, 2017 / Parrish Healthcare has opened a new healthcare facility at Port Canaveral that will provide a primary care/walk-in clinic as well as occupational medicine services, workers’ compensation care, diagnostics, physical therapy, industrial rehabilitation and sleep disorder services. The center is open from 7 a.m. to 7 p.m. on weekdays, and 7 a.m. to 4 p.m. on Saturdays and Sundays.

“We are proud to welcome aboard Parrish Healthcare to the Port community and congratulate them on the opening of their new facility. The availability of healthcare services from this on-port location is important for the seafaring community here. Cruise guests, crew members and shore-side support staff in close proximity to the cruise and cargo operations will have easy access to healthcare that was not before available in our immediate area,” said Port CEO Capt. John Murray.

Parrish Healthcare Center at Port Canaveral, located at 390 Challenger Road, opposite Cruise Terminal #1, was completed on July 17, 2017. The project’s general contractor was RUSH Construction, Inc.

The single-story facility is approximately 10,000 square feet and includes examination rooms, imaging and lab services, a rehabilitation center, conference space, and doctors’ offices, among other services. Nitin M. Haté, MD, board-certified in Occupational Medicine and Environmental Medicine, will serve as the center’s medical director.

“In response to repeated requests from area businesses and communities, the Parrish Healthcare Center at Port Canaveral is one more way we are growing to provide more Brevard residents and visitors convenient access to superior health services,” said George Mikitarian, Parrish Healthcare president and chief executive officer.

The newest Parrish Healthcare Center opened Monday, July 17, 2017 at Port Canaveral. The facility includes primary and walk-in medical care, occupational medicine services, workers’ compensation care, diagnostics, physical therapy, industrial rehabilitation and sleep disorder services. The center, located at 390 Challenger Road, Cape Canaveral, is open from 7 a.m. to 7 p.m. on weekdays, and 7 a.m. to 4 p.m. on Saturdays and Sundays.

Community dignitaries joined Parrish Healthcare leaders to celebrate the opening of Parrish’s newest healthcare center at Port Canaveral. Left to right: George Mikitarian; Parrish Healthcare president and CEO; Jeremy Bradford, Parrish vice president Operations; Herman Cole, Jr., Parrish Board of Directors chair; Peggy Crooks, Parrish Board of Directors member; Robert Jordan, Jr., Parrish Board of Directors vice chair; Stan Retz, CPA, Parrish Board of Directors member; Micah Loyd, Canaveral Port Authority commissioner; Billie Fitzgerald, Parrish Board of Directors member; Jerry Allender, Canaveral Port Authority commissioner; Wayne Justice, Canaveral Port Authority vice chair; William Chivers, RUSH Construction, Inc. president; Nitin Haté, MD, Parrish Medical Group Medical Director; Justin Grantham, RUSH Construction, Inc. project manager; and Homi Cooper, MD, Parrish Medical Group.

About Parrish Healthcare

Parrish Healthcare includes the nation’s first Integrated Care certification from The Joint Commission: Parrish Medical Center, a Mayo Clinic Care Network member and one of the nation’s most recognized hospitals for clinical quality, patient safety, and healing environments; Parrish Medical Group (physicians), NCQA certified patient-centered medical homes; and Parrish Health Network, a network of multiple health insurance companies, Mayo Clinic Care Network, Nemours and other allied health providers working together to improve quality and safety and lower healthcare costs on behalf of individuals, families and businesses. For more information, visit www.parrishhealthcare.com.

CONTACT:

VERONICA DENT, APR
DIRECTOR, COMMUNICATIONS & COMMUNITY SERVICES
321-268-6110

SOURCE: Parrish Healthcare

ReleaseID: 474197

3 Power Hour Stocks To Put On Your Radar Now

CORAL GABLES, FL / ACCESSWIRE / August 30, 2017 / There are 3 stocks to watch as we enter Power Hour: Medical Imaging Corp. (MEDD), DryShips, Inc. (NASDAQ: DRYS) & VBI Vaccines, Inc. (VBIV).

Medical Imaging Corp. (MEDD) a provider of extensive medical imaging services to patients and client hospitals in the United States and Canada. The company has four Diagnostic Imaging Centers and they recently announced they upgraded their CT machine at their Naples, Florida location.

“Our Naples CT business has been growing throughout 2017, so it was important to have the software installed to meet the new federal standards and ensure that we had a stronger and newer CT machine with greater up time as we approach the start of our busy season this fall,” stated Mitch Geisler, CEO. “The machine has now been installed and we can resume scanning CT patients this week.”

(MEDD) has been trading in the price range of $0.09-0.10 over the course of this trading week. On Tuesday (8/29) the stock closed at a high of the day at $0.10. Access A Free (MEDD) Report, Here.

DryShips, Inc. (DRYS) a diversified owner of ocean going cargo vessels recently announced on Tuesday (8/29) that the company closed its previously announced private placement. Over the last seven trading sessions DRYS has seen a price per share swing increase of 14.04% from lows of $2.92 on Wednesday (8/23) to highs during pre-market trading on Wednesday (8/30) at $3.33.

VBI Vaccines, Inc. (VBIV) a commercial-stage biopharmaceutical company developing the next generation of vaccines to fight infectious disease and immune-oncology, announced on Wednesday the FDA approved its investigational new drug application for Sci-B-Vac ® phase 3 clinical program. Sci-B-VAC ® is a third generation hepatitis B vaccine and its approved for use in Israel and 14 other companies.

“The receipt of formal acceptance of our clinical program from both the FDA and Health Canada marks a significant milestone as we move forward to initiating enrollment later this year in this Phase 3 pivotal program,” stated Jeff Baxter, President and CEO of VBI. “This program is expected to be conducted at approximately 40 sites across the U.S., Canada and Europe.”

Since the beginning of this trading week (VBIV) is up 19.18% from lows on Monday (8/28) at $3.44 to pre-market highs on Wednesday morning at $4.10.

For free up to the minute financial news updates, text keyword HFNEWS to 474747.

About HeraldFinance.com

HeraldFinance.com (“HF”) is owned by MAD Media Publishing LLC, a Nevada corporation. HF produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. HF has not been compensated: an affiliate company of HF, MIDAM VENTURES LLC, has been compensated $150,000 by a non-affiliate 3rd party for a period beginning 8/8/2017 and ending 9/7/2017 to publicly disseminate information about MEDD. We own zero shares.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither HF nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.HeraldFinance.com/.

NO WARRANTY

HF, the Author, and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect, or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

Contact:

editor@heraldfinance.com

SOURCE: HeraldFinance.com

ReleaseID: 474210